Press release
Houston Law Firm McGehee, Chang, Barnes Announces $3.4 Million Jury Verdict
HOUSTON – The Houston law firm of McGehee, Chang, Barnes is announcing a $3.4 million verdict handed down against Austin-based Medicus Insurance Company after jurors found that the company committed unfair and deceptive practices when it wrongly denied insurance coverage to a Dallas doctor.In the verdict issued Aug. 17, 2011, a Dallas County jury found that Medicus misrepresented the quality and standards of its indemnification practices, resulting in millions of dollars in damages for the doctor.
“The insurance company tried to write between the lines of its own policy to save itself some money,” says Houston lawyer Jack McGehee, a former lead medical malpractice attorney for the U.S. Army. “If an insurance company wants to deny policyholders, then it needs to make those reasons clear in the policy, not pull them from thin air after the fact.”
Medicus denied the insurance claim after the doctor was sued by a former patient. The doctor, who was covering for the patient’s attending physician, testified that his only involvement consisted of two phone calls about the patient’s care during an overnight hospital shift. Unknown to the doctor, the patient became permanently paralyzed. Medicus argued that the doctor should have notified the company about the possibility of the lawsuit.
“The doctor’s practice group had purchased a Medicus ‘claims-made’ policy, meaning that a malpractice claim made during the policy period would be covered by Medicus,” says Stephen Barnes, a lawyer with McGehee, Chang, Barnes who is also a doctor. “Our physicians need insurance companies to keep their word.”
The case is Colombrito v Medicus Insurance Company, No. DC-10-02691. The verdict was issued in the 14th District Court in Dallas County.
For more information on the jury verdict against Medicus Insurance, contact Mary Flood at mary@androvett.com or 800-559-4534.
McGehee, Chang, Barnes represents individuals and businesses injured by the misconduct of others by combining its compassion for clients with an aggressive pursuit of each lawsuit. The firm’s litigation team includes a doctor who also is trained as a lawyer and attorneys with extensive expertise in business matters.
Jack McGehee
MCGEHEE CHANG, BARNES
1250 WOOD BRANCH PARK DR SUITE 625
HOUSTON, TX 77079
713-864-4000
txlaw@lawtx.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Houston Law Firm McGehee, Chang, Barnes Announces $3.4 Million Jury Verdict here
News-ID: 188904 • Views: …
More Releases for Medicus
Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pi …
In the biotech sector, meaningful news often serves as the spark that brings smaller companies into sharper investor focus. Clinical readouts, regulatory decisions, and strategic acquisitions can materially shift the outlook for a business that may have otherwise flown under the radar. These developments not only shape the future of a company's pipeline but can also reframe its value proposition in the eyes of the market. For investors, recognizing when…
Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend …
The crucial role of vaccines in protecting public health couldn't have been clearer than with the recent coronavirus pandemic. COVID-19 vaccines were instrumental in helping to reduce the spread of the virus, propelling vaccines to the top ten therapy category by sales as of 2023.
At the height of the pandemic, Cominarty, which was jointly developed by Pfizer and BioNTech, emerged as the leading covid vaccine, recording peak sales of about…
Medicus Pharma Ltd. (NASDAQ:MDCX): Novel Treatment For Basal Cell Carcinoma Coul …
Skin cancer is the most common form of cancer in the United States, with more than 9,500 cases getting diagnosed every day. In fact, more people are diagnosed with skin cancer each year in the U.S. than all other cancers combined.
The most common form of skin cancer is basal cell carcinoma (BCC), which accounts for over 5 million cases of all skin cancers diagnosed in the U.S. each year. Currently,…
Medicus Pharma Ltd. (NASDAQ: MDCX) Positioned for Growth in a $5 Trillion Biotec …
The global population is aging rapidly, with the number of people aged 65 and older expected to double by 2050. This demographic shift is driving a surge in chronic diseases such as cancer, autoimmune disorders, and cardiovascular conditions. At the same time, breakthroughs in biomedical research are enabling the development of targeted, more effective therapies, transforming treatment approaches in both human and veterinary medicine.
These twin forces, rising demand fueled by…
Pediatric Tourniquet Market Scope By Players - Safeguard Medical, DarMar, Medicu …
MarketsandResearch.biz has newly added a research report titled Pediatric Tourniquet Market 2023 is a detailed and dedicated analysis of the present scenario of the market covering the various aspects applicable to business growth. The report evaluates the market, putting forth all-inclusive data that enriches the scope, understanding, and application of this report. The report encompasses the information on the global Pediatric Tourniquet market's status. It presents a detailed analysis of…
X-Ray Cassette Holders market: High-growth Segments and their Share Forecasts | …
"The global X-Ray Cassette Holders Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global X-Ray Cassette Holders Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of…